acet: the income statement

MyFinsight

Adicet Bio, Inc. (ACET)

For the quarter ending 2025-06-30, ACET made $1,398K in revenue. -$31,249K in net income. Net profit margin of -2235.26%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Unrealized loss on treasury securities, net of tax	-32
Total other comprehensive loss	-32
Income tax provision	-
Other expense, net	-223
Research and development	28,424
General and administrative	3,968
Total operating expenses	32,392
Loss from operations	-32,392
Interest expense	-
Interest income	1,398
Loss before income tax provision	-31,217
Net loss	-31,217
Comprehensive loss	-31,249

Earnings per share, basic, total	-0.34
Earnings per share, diluted, total	-0.34
Weighted average number of shares outstanding, basic, total	91,085,506
Weighted average number of shares outstanding, diluted, total	91,085,506

Unit: Thousand (K) dollars (except for numbers of shares and EPS)